Merrimack Pharmaceuticals
MACK
#7969
Rank
NZ$0.37 B
Marketcap
$25.26
Share price
0.00%
Change (1 day)
1.81%
Change (1 year)

Earnings for Merrimack Pharmaceuticals (MACK)

Earnings in 2024 (TTM): -NZ$3.72 Million

According to Merrimack Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$3.64 Million a decrease over its 2022 earnings that were of -NZ$3.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Merrimack Pharmaceuticals from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$3.72 Million2.38%
2023 -NZ$3.64 Million0.09%
2022 -NZ$3.63 Million-16.9%
2021 -NZ$4.37 Million-49.89%
2020 -NZ$8.72 Million-75.39%
2019 -NZ$35.42 Million-68.58%
2018 -NZ$0.12 Billion-19.4%
2017 -NZ$0.14 Billion-36.46%
2016 -NZ$0.23 Billion2.54%
2015 -NZ$0.22 Billion96.78%
2014 -NZ$0.11 Billion-45.44%
2013 -NZ$0.2 Billion
2010 -NZ$77.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$13.26 B-351,673.26%๐Ÿ‡ซ๐Ÿ‡ท France
-NZ$48.49 Million 1,185.48%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.27 Billion 6,808.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.37 Billion 9,523.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$63.04 Million 1,571.40%๐Ÿ‡บ๐Ÿ‡ธ USA